In some mouse tumor models, blockade of CSF1R has been shown to dramatically reduce TAM density [3, 4], or promote the induction of pro-inflammatory TAM phenotypes [5, 6], leading to immune activation and tumor regression [7]. Here, CSF1R is linked to neoplasm.